Obesity / Metabolic Syndrome

AACE 2017 Obesity Management AACE 2017 Obesity Management AACE 2017 Obesity Management AACE 2017 Obesity Management AACE 2017 Obesity Management AACE 2017 Obesity Management AACE 2017 Obesity Management AACE 2017 Obesity Management AACE 2017 OVERWEIGHT / OBESITY: Assess for CVDs and DM Complications and define the goal of A1C and modality of treatment Assess for intensity of weight loss Treatment Lifestyle Modification Medical Therapy: Assess for Efficacy, Side effects, Costs Surgical Therapy  AACE DM Management Algorithm 2013 Obesity/Metabolic Syndrome Bariatric surgery for obesity and metabolic conditions in adults BMJ 2014 Pharmacotherapy for weight loss BMJ 2014  Long-term Drug Treatment for Obesity A Systematic and Clinical Review JAMA 2014 New Obesity Guidelines Promise and Potential JAMA 2013 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults JACC 2013 Obesity In the Clinic Annals 2013 ObesityWeight Loss, Exercise, or Both and Physical Function in Obese Older Adults A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice General and Abdominal Obesity and Risk of Death among Black Women Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects Metabolic Syndrome  Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance CPAP for the Metabolic Syndrome in Patients with Obstructive Sleep Apnea Effect of Ramipril on the Incidence of Diabetes Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin NEJM 2002 Madelung’s Disease NEJM 2016 (mitochondrial dysfunction with reduced activity of the enzyme cytochrome c oxidase)